Growth Metrics

KalVista Pharmaceuticals (KALV) Debt Ratio (2014 - 2016)

KalVista Pharmaceuticals recorded quarterly Debt Ratio of 0.09 in Q1 2016, up 15.37% quarter-over-quarter from 0.08 in Q4 2015, and down 83.88% year-over-year from 0.58 in Q2 2015.

KalVista Pharmaceuticals' Debt Ratio history runs 3 years deep, the most recent figure standing at 0.09 for Q1 2016.

  • In Q1 2016, Debt Ratio fell 83.88% year-over-year to 0.09; the TTM figure through Mar 2016 stood at 0.09 (down 83.88% YoY), while the FY2016 annual figure was 0.01, changed N/A from the prior year.
  • Debt Ratio came in at 0.09 for Q1 2016 at KalVista Pharmaceuticals, up from 0.08 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.67 in Q4 2014 to a low of 0.07 in Q2 2015.
  • A 3-year average of 0.26 and a median of 0.09 in 2015 frame the typical range for Debt Ratio.
  • Across the five-year window, Debt Ratio tumbled 87.84% in 2015 and sank 83.88% in 2016, its largest moves.
  • KalVista Pharmaceuticals' Debt Ratio stood at 0.67 in 2014, then sank by 87.84% to 0.08 in 2015, then advanced by 15.37% to 0.09 in 2016.
  • According to Business Quant data, Debt Ratio over the past three periods registered 0.09, 0.08, and 0.07 for Q1 2016, Q4 2015, and Q3 2015 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 0.18
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 1.41
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 0.05
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 KalVista Pharmaceuticals 1.44 Bn 1.25 Bn 56.41 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2016 0.09
Dec 31, 2015 0.08
Sep 30, 2015 0.07
Jun 30, 2015 0.07
Mar 31, 2015 0.58
Dec 31, 2014 0.67